Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $16,475 | 2 | 96.1% |
| Food and Beverage | $665.43 | 31 | 3.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $16,475 | 2 | $0 (2023) |
| Smith+Nephew, Inc. | $439.53 | 20 | $0 (2023) |
| Organogenesis Inc. | $57.15 | 1 | $0 (2019) |
| Hologic Sales and Service, LLC | $38.34 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $35.15 | 2 | $0 (2018) |
| Shire North American Group Inc | $21.10 | 1 | $0 (2017) |
| NOVADAQ TECHNOLOGIES INC. | $17.58 | 1 | $0 (2017) |
| Innovative Therapies Inc. | $17.15 | 1 | $0 (2017) |
| Melinta Therapeutics, LLC | $15.57 | 1 | $0 (2020) |
| ConvaTec Inc. | $13.91 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.29 | 3 | Hologic Sales and Service, LLC ($38.34) |
| 2023 | $11,628 | 2 | Becton, Dickinson and Company ($11,600) |
| 2022 | $5,043 | 7 | Becton, Dickinson and Company ($4,875) |
| 2021 | $30.06 | 2 | Smith+Nephew, Inc. ($16.15) |
| 2020 | $27.27 | 2 | Melinta Therapeutics, LLC ($15.57) |
| 2019 | $124.39 | 5 | Smith+Nephew, Inc. ($67.24) |
| 2018 | $119.12 | 6 | Smith & Nephew, Inc. ($83.97) |
| 2017 | $120.50 | 6 | Smith & Nephew, Inc. ($64.67) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/01/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diagnostics | ||||||
| 03/07/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Diagnostics | ||||||
| 09/22/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Pharma Products | ||||||
| 02/08/2023 | Becton, Dickinson and Company | BD Veritor Plus Analyzer (Device) | — | Cash or cash equivalent | $11,600.00 | Research |
| Study: COVID-19 • Category: Diagnostic Testing | ||||||
| 12/19/2022 | Becton, Dickinson and Company | BD Veritor InfoScan Module (Device) | — | Cash or cash equivalent | $4,875.00 | Research |
| Study: COVID-19 • Category: Diagnostic Systems | ||||||
| 10/11/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Pharma Products | ||||||
| 10/07/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Pharma Products | ||||||
| 08/30/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Pharma Products | ||||||
| 07/20/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Pharma Products | ||||||
| 05/24/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Pharma Products | ||||||
| 02/09/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Pharma Products | ||||||
| 03/23/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Pharma Product | ||||||
| 01/12/2021 | ConvaTec Inc. | AQUACEL Ag Advantage (Device) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Advanced Wound Care | ||||||
| 05/13/2020 | Melinta Therapeutics, LLC | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ANTIBIOTICS | ||||||
| 02/08/2020 | Smith+Nephew, Inc. | OASIS (Device) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Extra Cellular Matrix | ||||||
| 12/18/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Pharma Product | ||||||
| 11/18/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Pharma Product | ||||||
| 10/10/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Pharma Product | ||||||
| 06/14/2019 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $57.15 | General |
| Category: Wound Care | ||||||
| 05/01/2019 | Smith+Nephew, Inc. | Stravix (Biological), Grafix, GrafixPL | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Other Advanced Wound Management | ||||||
| 09/17/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/13/2018 | Smith & Nephew, Inc. | Santyl (Drug), Regranex | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Pharma Product | ||||||
| 04/16/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/12/2018 | Smith & Nephew, Inc. | Santyl (Drug), Regranex | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Pharma Product | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| COVID-19 | Becton, Dickinson and Company | $16,475 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,943 | 2,880 | $289,774 | $121,281 |
| 2022 | 22 | 2,035 | 2,990 | $290,225 | $123,173 |
| 2021 | 31 | 4,783 | 5,793 | $381,991 | $202,198 |
| 2020 | 13 | 773 | 992 | $134,893 | $55,352 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 470 | 563 | $81,526 | $35,111 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 240 | $47,135 | $23,878 | 50.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 302 | 302 | $65,078 | $22,699 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $33,671 | $15,210 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 103 | 152 | $25,522 | $11,632 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 46 | 46 | $11,927 | $4,968 | 41.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 136 | 182 | $9,348 | $1,913 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 28 | $2,949 | $1,444 | 49.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 42 | 43 | $2,337 | $825.08 | 35.3% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 17 | 17 | $1,314 | $530.51 | 40.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 18 | 18 | $1,541 | $502.64 | 32.6% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 15 | 15 | $1,086 | $472.20 | 43.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 119 | 125 | $1,250 | $426.25 | 34.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 11 | $731.28 | $324.06 | 44.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 26 | $1,038 | $299.50 | 28.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 17 | 17 | $362.61 | $275.40 | 75.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 30 | 31 | $1,177 | $215.60 | 18.3% |
| 81025 | Urine pregnancy test | Office | 2023 | 19 | 22 | $308.00 | $185.68 | 60.3% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 18 | 18 | $607.24 | $153.18 | 25.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 74 | 178 | $231.40 | $67.88 | 29.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 19 | 19 | $247.00 | $60.99 | 24.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 60 | 585 | $146.25 | $50.33 | 34.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 25 | 92 | $187.68 | $32.90 | 17.5% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2023 | 28 | 30 | $54.87 | $2.79 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 470 | 575 | $84,055 | $40,318 | 48.0% |
About Brian Bearie
Brian Bearie is a Emergency Medicine healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386754216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Bearie has received a total of $17,140 in payments from pharmaceutical and medical device companies, with $48.29 received in 2024. These payments were reported across 33 transactions from 11 companies. The most common payment nature is "" ($16,475).
As a Medicare-enrolled provider, Bearie has provided services to 9,534 Medicare beneficiaries, totaling 12,655 services with total Medicare billing of $502,004. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location San Bernardino, CA
- Active Since 08/30/2006
- Last Updated 09/27/2013
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1386754216
Products in Payments
- BD Veritor Plus Analyzer (Device) $11,600
- BD Veritor InfoScan Module (Device) $4,875
- COLLAGENASE SANTYL (Drug) $211.95
- Santyl (Drug) $184.60
- Apligraf (Device) $57.15
- SIVEXTRO (Drug) $35.15
- THINPREP 2000 PROCESSOR (Device) $24.62
- CUVITRU (Biological) $21.10
- PICO (Device) $18.51
- SPY Technology (Device) $17.58
- Orbactiv (Drug) $15.57
- AQUACEL Ag Advantage (Device) $13.91
- APTIMA (Device) $13.72
- Stravix (Biological) $12.77
- OASIS (Device) $11.70
- PAXLOVID (Drug) $9.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in San Bernardino
Nyda Pamintuan, Md, MD
Emergency Medicine — Payments: $951.04
Yasmina Boyd, M.d, M.D
Emergency Medicine — Payments: $137.55
Sabina Moore-Cohen, Md, MD
Emergency Medicine — Payments: $83.53
Matthew Stilson, M.d, M.D
Emergency Medicine — Payments: $45.42
Micah Wittler, D.o, D.O
Emergency Medicine — Payments: $28.97
Debbie Bervel, Md, MD
Emergency Medicine — Payments: $16.32